Cargando…
Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study
This study assessed the effects of the serotonin (5-HT) and norepinephrine (NE) transporter inhibitor duloxetine on the effects of 3,4–methylenedioxymethamphetamine (MDMA, ecstasy) in vitro and in 16 healthy subjects. The clinical study used a double-blind, randomized, placebo-controlled, four-sess...
Autores principales: | Hysek, Cédric M., Simmler, Linda D., Nicola, Valentina G., Vischer, Nerina, Donzelli, Massimiliano, Krähenbühl, Stephan, Grouzmann, Eric, Huwyler, Jörg, Hoener, Marius C., Liechti, Matthias E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344887/ https://www.ncbi.nlm.nih.gov/pubmed/22574166 http://dx.doi.org/10.1371/journal.pone.0036476 |
Ejemplares similares
-
Malignant hyperpyrexia in an MDMA ("Ecstasy") abuser.
por: McCoy, E. P., et al.
Publicado: (1994) -
Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): Neurodegeneration versus Neuromodulation
por: Puerta, Elena, et al.
Publicado: (2011) -
Ecstasy (MDMA): A rebellion coherent with the
system
por: García-Montes, José Manuel, et al.
Publicado: (2020) -
Ecstasy (MDMA) and its effects on kidneys and their treatment: a review
por: Bora, Feyza, et al.
Publicado: (2016) -
Caffeine and MDMA (Ecstasy) Exacerbate ER Stress Triggered by Hyperthermia
por: Trychta, Kathleen A., et al.
Publicado: (2022)